tiprankstipranks
Kiromic Biopharma, Inc. (KRBP)
:KRBP
US Market

Kiromic Biopharma (KRBP) Income Statement

Compare
19 Followers

Kiromic Biopharma Income Statement

Last quarter (Q4 2024), Kiromic Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Kiromic Biopharma's net income was $-6.49M. See Kiromic Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -2.80M$ -2.07M$ -469.80K$ -200.00K
Operating Expenses
$ 23.77M$ 17.14M$ 31.11M$ 25.31M$ 19.20M
Depreciation and Amortization
$ 0.00$ 2.80M$ 2.07M$ 469.80K$ 200.00K
EBITDA
$ -23.77M$ -16.30M$ -32.50M$ -25.74M$ -19.00M
Operating Income
$ -23.77M$ -19.94M$ -31.11M$ -25.74M$ -19.20M
Other Income/Expenses
$ -3.12M$ -1.01M$ -3.62M$ 147.00K$ -3.30K
Pretax Income
$ -26.90M$ -20.95M$ -34.73M$ -25.59M$ -19.20M
Net Income
$ -26.90M$ -21.29M$ -38.18M$ -25.65M$ -19.20M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.03$ -21.41$ -70.12$ -67.40$ -79.08
Diluted EPS
$ -1.03$ -21.41$ -70.12$ -67.40$ -79.08
Weighted Average Shares Outstanding
26.07M 32.93M 544.53K 380.61K 242.83K
Weighted Average Shares Outstanding (Diluted)
26.07M 32.93M 544.53K 380.61K 242.83K
Currency in USD

Kiromic Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis